Have a personal or library account? Click to login
Effectiveness of Ropeginterferon Alfa-2B in High-Risk Patients with Philadelphia Chromosome Negative Myeloproliferative Neoplasms– Evaluation of Clinicohaematologic Response, and Safety Profile: Single Centre Experience Cover

Effectiveness of Ropeginterferon Alfa-2B in High-Risk Patients with Philadelphia Chromosome Negative Myeloproliferative Neoplasms– Evaluation of Clinicohaematologic Response, and Safety Profile: Single Centre Experience

Open Access
|Dec 2023
DOI: https://doi.org/10.2478/prilozi-2023-0047 | Journal eISSN: 1857-8985 | Journal ISSN: 1857-9345
Language: English
Page range: 57 - 62
Published on: Dec 18, 2023
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2023 Marija Popova-Labachevska, Milche Cvetanoski, Nevenka Ridova, Sanja Trajkova, Simona Stojanovska-Jakimovska, Tara Mojsovska, Zlate Stojanoski, Aleksandra Pivkova-Veljanovska, Irina Panovska-Stavridis, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.